News stories about Clorox (NYSE:CLX) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Clorox earned a coverage optimism score of 0.22 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.267853721067 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:
- Clorox (CLX) Price Target Cut to $138.00 by Analysts at JPMorgan Chase & Co. (americanbankingnews.com)
- Clorox to buy Nutranext for US$700mln in deal expanding its dietary supplements business (proactiveinvestors.co.uk)
- Clorox (CLX) to Acquire Nutranext for $700 Million (streetinsider.com)
- Hidden Valley First To Leverage Allrecipes’ AmazonFresh Integration (finance.yahoo.com)
- Clorox to buy dietary supplements maker Nutranext for $700 million – Reuters (uk.reuters.com)
CLX has been the subject of a number of research reports. Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $163.00 price objective for the company in a research report on Monday, January 8th. BMO Capital Markets set a $147.00 price objective on Clorox and gave the company a “buy” rating in a research report on Monday, February 5th. Morgan Stanley reduced their price objective on Clorox from $140.00 to $133.00 and set an “equal weight” rating for the company in a research report on Monday, February 5th. Jefferies Group reiterated a “hold” rating and set a $148.00 price objective on shares of Clorox in a research report on Thursday, January 4th. Finally, Wells Fargo & Co reiterated a “hold” rating and set a $130.00 price objective on shares of Clorox in a research report on Wednesday, December 13th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $132.61.
Clorox (NYSE:CLX) last released its quarterly earnings results on Friday, February 2nd. The company reported $1.23 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.22 by $0.01. Clorox had a return on equity of 126.70% and a net margin of 13.21%. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the previous year, the company posted $1.14 earnings per share. Clorox’s revenue for the quarter was up .7% on a year-over-year basis. equities analysts anticipate that Clorox will post 6.23 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, May 11th. Shareholders of record on Wednesday, April 25th will be issued a dividend of $0.96 per share. This represents a $3.84 annualized dividend and a yield of 2.93%. The ex-dividend date is Tuesday, April 24th. This is a positive change from Clorox’s previous quarterly dividend of $0.84. Clorox’s payout ratio is currently 61.65%.
COPYRIGHT VIOLATION WARNING: “Clorox (CLX) Receiving Somewhat Positive News Coverage, Report Finds” was published by BBNS and is owned by of BBNS. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright law. The correct version of this report can be read at https://baseballnewssource.com/2018/03/13/clorox-clx-receiving-somewhat-positive-news-coverage-report-finds/2025702.html.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.